Approval · Notice of Compliance 2463 · 2001
NARCAN: Notice of Compliance 2463
Issued November 22, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2463
- Date
- November 22, 2001
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Narcotic antagonist
Products in this notice
Medicinal ingredients
- NALOXONE HYDROCHLORIDE 0.4 MG per ML
- NALOXONE HYDROCHLORIDE 0.02 MG per ML
- NALOXONE HYDROCHLORIDE 1 MG per ML